Filing metadata

Accession number
0000899243-23-005052
Form type
Form 5
Filer
CTI BIOPHARMA CORP
CIK
CIK 891293
Filed
Feb 14, 2023
Reporting period
Dec 31, 2022
Description
Annual insider statement

Explore SEC Filings Hub